Literature DB >> 18514651

A comparative study of 50% dextrose and normal saline solution on their ability to create submucosal fluid cushions for endoscopic resection of sessile rectosigmoid polyps.

Panagiotis Katsinelos1, Jannis Kountouras, George Paroutoglou, Grigoris Chatzimavroudis, Christos Zavos, Ioannis Pilpilidis, George Gelas, Dimitris Paikos, Konstantinos Karakousis.   

Abstract

BACKGROUND: EMR traditionally performed by using normal saline solution (NS) plus epinephrine (E) as a submucosal fluid cushion does not maintain the submucosal elevation for a prolonged time. It was hypothesized that 50% dextrose (D(50)) plus E as a hypertonic, inexpensive, and easily available solution might be an ideal alternative for producing and maintaining more-prolonged mucosal elevation.
OBJECTIVE: To evaluate D(50)+E versus NS+E during an EMR of sessile rectosigmoid polyps (> 10 mm).
DESIGN: A prospective, double-blind, randomized study that compared EMR by using either D(50)+E or NS+E submucosal fluid cushions.
SETTING: Four tertiary endoscopic referral centers with 1370 polypectomies in 2006, performed by 5 experienced endoscopists. PATIENTS: Patients treated for sessile rectosigmoid polyps (> 10 mm).
INTERVENTIONS: Polypectomy with D(50)+E or NS+E submucosal fluid cushions. MAIN OUTCOME MEASUREMENTS: The duration of submucosal elevation, volume of solution, number of required injections to maintain the elevation, and observations for complications.
RESULTS: Ninety-two sessile rectosigmoid polyps were removed. Injected solution volumes and the number of injections to maintain submucosal elevation were lower in the D(50)+E group than in the NS+E group (P = .033 and P = .028, respectively). Submucosal elevation had a longer duration in the D(50)+E group (P = .043). This difference mainly included large (> or = 20 mm) and giant (> 40 mm) polyps. There were 6 and 1 cases of postpolypectomy syndrome in the D(50)+E and NS+E groups, respectively (P = .01). LIMITATIONS: May be limited by inexperienced endoscopist's lack of injection and polypectomy skills.
CONCLUSIONS: D(50)+E is superior to NS+E for an EMR, particularly in large and giant sessile polyps, but the risk of thermal tissue injury should be considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514651     DOI: 10.1016/j.gie.2008.02.063

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  19 in total

Review 1.  Application of hydrogels as submucosal fluid cushions for endoscopic mucosal resection and submucosal dissection.

Authors:  Masayuki Ishihara; Isao Kumano; Hidemi Hattori; Shingo Nakamura
Journal:  J Artif Organs       Date:  2015-05-23       Impact factor: 1.731

2.  A New Ex Vivo Model for the Evaluation of Endoscopic Submucosal Injection Material Performance.

Authors:  Ryohei Hirose; Tomo Daidoji; Yuji Naito; Osamu Dohi; Naohisa Yoshida; Hiroaki Yasuda; Hideyuki Konishi; Takaaki Nakaya; Yoshito Itoh
Journal:  J Vis Exp       Date:  2018-10-19       Impact factor: 1.355

3.  Endoscopic submucosal dissection for gastric neoplasm in patients with co-morbidities categorized according to the ASA Physical Status Classification.

Authors:  Mariko Man-i; Yoshinori Morita; Tsuyoshi Fujita; James E East; Shinwa Tanaka; Chika Wakahara; Masaru Yoshida; Takanobu Hayakumo; Hiromu Kutsumi; Hideto Inokuchi; Takashi Toyonaga; Takeshi Azuma
Journal:  Gastric Cancer       Date:  2012-03-02       Impact factor: 7.370

4.  Clinical features and predictive factors of coagulation syndrome after endoscopic submucosal dissection for early gastric neoplasm.

Authors:  Hyuk Lee; Kyung Seok Cheoi; Hyunsoo Chung; Jun Chul Park; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Gastric Cancer       Date:  2011-07-15       Impact factor: 7.370

5.  Tissue apposition system: new technology to minimize surgery for endoscopically unresectable colonic polyps.

Authors:  C P Delaney; B J Champagne; J M Marks; L Sanuk; B Ermlich; A Chak
Journal:  Surg Endosc       Date:  2010-05-19       Impact factor: 4.584

6.  Randomized controlled trial investigating use of submucosal injection of EverLift™ in rates of complete resection of non-pedunculated 4-9 mm polyps.

Authors:  Mike T Wei; Christine Y Louie; Yu Chen; Jennifer Y Pan; Susan Y Quan; Robert Wong; Ryanne Brown; Melissa Clark; Kristin Jensen; Hubert Lau; Shai Friedland
Journal:  Int J Colorectal Dis       Date:  2022-05-04       Impact factor: 2.571

7.  Gastric endoscopic submucosal dissection using sodium carboxymethylcellulose as a new injection substance.

Authors:  Takuto Hikichi; Masahiro Yamasaki; Ko Watanabe; Jun Nakamura; Masaki Sato; Tadayuki Takagi; Rei Suzuki; Mitsuru Sugimoto; Hitomi Kikuchi; Naoki Konno; Yuichi Waragai; Hiroyuki Asama; Mika Takasumi; Yutaka Ejiri; Hiroshi Watanabe; Hiromasa Ohira; Katsutoshi Obara
Journal:  Fukushima J Med Sci       Date:  2016-03-26

8.  Minimally invasive approaches for the management of "difficult" colonic polyps.

Authors:  R Alejandro Cruz; Madhu Ragupathi; Rodrigo Pedraza; T Bartley Pickron; Anne T Le; Eric M Haas
Journal:  Diagn Ther Endosc       Date:  2011-06-28

9.  Utility and performance characteristics of a novel submucosal injection agent (EleviewTM) for endoscopic mucosal resection and endoscopic submucosal dissection.

Authors:  Mohit Girotra; George Triadafilopoulos; Shai Friedland
Journal:  Transl Gastroenterol Hepatol       Date:  2018-06-19

10.  Efficacy of submucosal injection of different solutions inclusive blood components on mucosa elevation for endoscopic resection.

Authors:  Oliver H Al-Taie; Yildiz Bauer; Christoph G Dietrich; Wolfgang Fischbach
Journal:  Clin Exp Gastroenterol       Date:  2012-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.